Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kristin Patrick is Director at Laird Superfood. OQRO lists 3 transactions filed with the SEC under this name, the latest on Jul 13, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
1
Laird SuperfoodLSF
3 disclosures · Jul 2026
Jul 9, 202660Kdisclosed Jul 13
DetailsOfficial recordJul 9, 202625Kdisclosed Jul 13
DetailsOfficial recordJul 9, 202625Kdisclosed Jul 13
DetailsOfficial recordKristin Patrick has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2024.
Niagen Bioscience (NAGE), from 2024 to 2024: 0 purchases and 1 sale.
Kristin Patrick has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
Kristin Patrick reported 0 open-market purchases and 1 sale since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $82K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Kristin Patrick reported 0 open-market purchases and 1 sale here, 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
